Complex Innovative Design
Decentralized Clinical Trials
European Medicines Agency
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Outsourcing Clinical Trials
Real-World Evidence (RWE)
Research & Development
Research and Development
RWE Decision Alert
Biotechs on the Rise
In the final article of our Biotech series, Joris Pezzini talks about the evolution of biotechs in the face of challenges and the drivers for future success.
Inflation Reduction Act and Pharma – Navigating Uncertainty
What's the impact of the Inflation Reduction Act on small biotechs, mid-size companies and large pharma players, and how can they prepare?
Execution: How Biotechs Can Plan and Run Successful Clinical Trials
Biotech experts Joris Pezzini and Chris Rao answer questions about the challenges of executing a successful clinical trial.
What EU Companies Need to Know about the U.S. Inflation Reduction Act
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
Fundraising: Best Practices in a Challenging Environment
Experts Joris Pezzini and Dan Pastore discuss the importance of fundraising, one of the three required jobs for successful biotech leaders.
2023 Biologics & Advanced Therapies Contract Manufacturing Report: Executive Summary
Get in-depth market analysis, detailed examination of transactional activity, and insight into development of Biologics and ATs CDMO services.
Planning: Why It’s Worth the Time for Biotech Companies
Biotech expert Joris Pezzini covers the fundamentals of planning, one of the three required jobs for biotech leaders to be successful.
The Biotech Industry Today: What Leaders Need to Know
Biotech companies today face a complex and often difficult funding, regulatory, and market access environment.
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
The State of Biopharma Funding
We spoke with Joris Pezzini, Executive Vice President of Biopharma, Alira Health, during the J.P. Morgan Healthcare Conference in San Francisco, which brings together investors and(...)
How to Choose the Right Analytical Methods for Biologics
Analytical method development is an important component of biologics development and the control of quality attributes that affect product performance and stability is critical to success.
Critical Quality Attributes for Drug Products
In this article, we will explore the importance of Critical Quality Attributes (CQAs) in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
What to Look for in a CDMO
In this article we will focus on the evaluation of a few identified CDMOs. There are several factors to consider and while some may be subjective to your company’s needs and culture,(...)
Latest from Alira Health
Pharma Develops e-Health Solution That Prioritizes Patients’ True Unmet Needs
A leading pharma company in the respiratory market sought support developing the right digital platform to expand their patient base and increase retention.
Bayesian Trial Design to Generate Evidence of the Safety and Efficacy of a Drug Regimen
A biotech company sought support in the design of their Phase II clinical trial to test the safety and efficacy of a novel inhibitor in combination with Pembrolizumab in patients with(...)
Leveraging a Virtual Site to Boost Diversity and Enrollment
The client’s study aimed to assess the sensitivity and specificity of a novel diagnostic test for colorectal cancer in a large population representative of the diversity in the US.
ACR Convergence 2023
We are pleased to announce that we will be joining ACR Convergence 2023, the world’s premier rheumatology event.
Spain Healthcare Innovation Summit
We will sponsor and speak at Spain Healthcare Innovation Summit, a premier event that brings together healthcare professionals from across Spain and beyond to discuss the latest developments(...)
Virtual Startup Demo Day
Join us and hear pitches from the leading startups in New England and beyond at the MassMedic Startup Virtual Demo Day.
How to Accelerate Lupus Solutions with RWD
Explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency.
How to Increase Patient Engagement in Your Clinical Trials
Join this webinar hosted by France Biotech to learn best practices and how to overcome challenges in engaging patients in your clinical trial.
Clinical Trials & Hospital Pilots
Kenny Carberry, VP, Business Development, Research & Clinical Development, joins the “Clinical Trials & Hospital Pilots” webinar as speaker.
Alira Health to Present at the Piper Sandler 35th Annual Healthcare Conference
Alira Health announced that Gabriele Brambilla, Alira Health’s Chief Executive Officer and Co-Founder, and Piergiulio Lauriano, Chief Strategy Officer at Alira Health, will present(...)
Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions
Alira Health and FORWARD announced the launch of the enhanced Lupus Registry, enabling patients, caregivers, and research sponsors to gain better insights, and achieve better patient outcomes.
Alira Health Partners with the Patient Empowerment Network Enabling Cancer Patients to Take Control of their Health and Treatment
Alira Health and the Patient Empowerment Network announced their partnership in supporting those impacted by cancer with a mobile platform delivering essential support for their medical needs.
SOHONOS, the First Drug for Fibrodysplasia Ossificans Progressiva, Receives US FDA Approval with Real-World Evidence as External Control
SOHONOS, the first drug for fibrodysplasia ossificans progressiva, receives US FDA approval with Real-World Evidence as external control
Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
Immunoglobulin Fc-Fusion Proteins
Our experts published a series of articles in BioProcess International reviewing the state of the art of Fc – fusion proteins, including their structure and molecular design, manufacturing(...)